OncoMimics

Paris, France | July 21, 2026 Enterome SA announced positive interim Phase 1/2 clinical data from its ongoing SIDNEY...

Paris, France | May 28, 2026 Enterome announced that the U.S. FDA has granted Orphan Drug Designation (ODD) to...

Paris, France – October 16, 2025 – The U.S. Food and Drug Administration (FDA) has granted Fast Track designation...